Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 70518-1819

7 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 70518-1819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Rosuvastatin Structure)

Structure (Rosuvastatin Structure)
Chemical structure of Rosuvastatin Calcium, showing the molecular arrangement with calcium ions (Ca2+) as part of the compound.*
FDA Label Image

Rosuvastatin-fig-01 (Rosuvastatin Fig 01)

Rosuvastatin-fig-01 (Rosuvastatin Fig 01)
A line graph depicting cumulative incidence percentage over a 5-year period comparing Rosuvastatin (solid line) versus Placebo (dotted line). The graph includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) with statistical significance (P<0.001). Numbers at risk for RSV and Placebo groups are noted for multiple years along the x-axis.*
FDA Label Image

Rosuvastatin-fig-02 (Rosuvastatin Fig 02)

Rosuvastatin-fig-02 (Rosuvastatin Fig 02)
A forest plot chart comparing the number of events between Rosuvastatin Calcium 20 mg and placebo 20 mg groups across cardiovascular endpoints, including primary endpoint, cardiovascular death, nonfatal stroke, nonfatal myocardial infarction, hospitalized unstable angina, and arterial revascularization. The chart displays hazard ratios with 95% confidence intervals and p-values for each endpoint, showing relative risk reduction or increase associated with Rosuvastatin Calcium 20 mg versus placebo.*
FDA Label Image

Rosuvastatin-fig-03 (Rosuvastatin Fig 03)

Rosuvastatin-fig-03 (Rosuvastatin Fig 03)
A box-and-whisker plot comparing the percent change from baseline in LDL cholesterol levels for four statins: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. Each statin is shown at various doses from 10 mg up to 80 mg, illustrating the range and distribution of LDL-c reduction effects.*
FDA Label Image

Mm1 (Rosuvastatin 20mg 70518 1819 00)

Mm1 (Rosuvastatin 20mg 70518 1819 00)
Label for Rosuvastatin Calcium 20 mg film-coated tablets, package quantity 90 tablets. The label includes the NDC number 70518-1819-00 and indicates the tablets are round, pink, and marked with R20. It states the medication is prescription-only and repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer is Novadoz Pharma LLC, Piscataway, NJ.*
FDA Label Image

Mm2 (Rosuvastatin 20mg 70518 1819 01)

Mm2 (Rosuvastatin 20mg 70518 1819 01)
Rosuvastatin 20 mg film-coated tablets, quantity 45, labeled by RemedyRepack Inc. The label includes NDC 70518-1819-01 and manufacturing information from Novadoz Pharmaceuticals LLC, Piscataway, NJ. Directions note to see package insert, storage temperature guidance, and a QR code is present on the label.*
FDA Label Image

Mm3 (Rosuvastatin 20mg 70518 1819 02)

Mm3 (Rosuvastatin 20mg 70518 1819 02)
Rosuvastatin 20 mg film-coated tablets label from RemedyRepack Inc. The label indicates a quantity of 30 tablets and includes the NDC number 70518-1819-02. It notes the original manufacturer as Novadoz Pharmaceuticals LLC, Piscataway, NJ. Instructions reference the package insert for directions for use, with storage conditions provided.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.